| Trial ID: | L0091 |
| Source ID: | NCT01103336
|
| Associated Drug: |
Pretreatment With Intravenous Nicorandil Vs. Placebo Before Coronary Angiography
|
| Title: |
Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: pretreatment with intravenous nicorandil vs. placebo before coronary angiography
|
| Outcome Measures: |
Primary: Incidence of contrast-induced nephropathy defined as an increase in serum creatinine ≥25% or ≥0.5 mg/dl, at 24 hours |
|
| Sponsor/Collaborators: |
Sponsor: Yonsei University | Collaborators: GE Healthcare
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
173
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2010-03
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-02-06
|
| Locations: |
Severance Hospital, Seoul, 120-752, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01103336
|
